Annual report pursuant to Section 13 and 15(d)

Business (Details Narrative)

v3.24.0.1
Business (Details Narrative)
12 Months Ended
Dec. 31, 2023
USD ($)
Integer
Dec. 31, 2022
USD ($)
Patents owned by the company 100  
Expired patents 54  
Foreign patents owned by the company 15  
ILiAD Biotechnologies LLC [Member]    
Aggregate investment amount | $ $ 7,000,000 $ 7,000,000